Skip to main content

Security report for medivir.com

Medivir AB · Healthcare · Sweden

Medium risk. 7 critical or high findings in GDPR outside view, SSL/TLS and 1 other check.

Security score

51/100

Risk levelMedium

0–100, higher is better. How it is calculated

Medivir AB is a Swedish pharmaceutical company specializing in the discovery and development of innovative cancer drugs, leveraging expertise in protease inhibitor design and nucleoside/nucleotide science. The company targets cancers with high unmet medical needs and operates through proprietary projects, licensing, and partnerships. Their website reflects a professional and consistent brand image with comprehensive investor relations and transparent contact information. Technically, the site uses modern web technologies such as jQuery, Video.js, and Headroom.js, and is likely powered by the Umbraco CMS. The site is mobile-optimized and SEO-friendly, though accessibility could be improved. Security posture is strong with HTTPS enforced and cookie consent implemented, but lacks explicit security headers and published security policies. Overall, the domain registration aligns well with the business claims, indicating legitimacy and trustworthiness.

Scanned

NIS2 and GDPR posture

GDPR outside view
28/ 100 · High
Checks completed
7of 7

NIS2 Art. 21(2)

  1. (a) Risk analysis and security policies: Not visible from outside
  2. (b) Incident handling: One indicator
  3. (c) Business continuity, backups and crisis management: Not visible from outside
  4. (d) Supply chain security: Not visible from outside
  5. (e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
  6. (f) Assessing the effectiveness of security measures: Not visible from outside
  7. (g) Cyber hygiene and security training: Not visible from outside
  8. (h) Cryptography and encryption: Partly checked
  9. (i) HR security, access control and asset management: One indicator
  10. (j) Multi-factor authentication and secured communications: Not visible from outside

This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.

GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.

Priority findings

7 findings rated critical or high. Fix these first.

  1. GDPR outside view

    These are the privacy signals visitors and data protection authorities look for under GDPR.

    • Critical

      No HTTPS encryption

      GDPR requires appropriate security measures for personal data

      What to do: Implement SSL/TLS certificate for HTTPS

  2. SSL/TLS

    TLS encrypts the connection and proves the site is really yours. Weak or expiring certificates trigger browser warnings and put traffic at risk.

    • Critical

      No HTTPS Encryption

      Website does not use HTTPS encryption, making all data transmission vulnerable to interception

      What to do: Implement SSL/TLS certificate and redirect all HTTP traffic to HTTPS

  3. Security headers

    Security headers are instructions your web server sends to every visitor’s browser. Missing ones leave visitors more exposed to attacks such as clickjacking and injected scripts.

    • High

      Missing Strict-Transport-Security header

      Forces HTTPS connections

      What to do: Add "Strict-Transport-Security: max-age=31536000; includeSubDomains; preload"

      • CWE-319
      • OWASP A04:2025
      • ASVS V3.4.1
    • High

      Missing X-Frame-Options header

      Prevents clickjacking attacks

      What to do: Add "X-Frame-Options: DENY" or "X-Frame-Options: SAMEORIGIN"

    • High

      Missing Content-Security-Policy header

      Controls resources the browser is allowed to load

      What to do: Implement a Content-Security-Policy appropriate for your application

      • ASVS V3.4.3
      • OWASP Secure Headers: OWASP Secure Headers Project recommends Content-Security-Policy: default-src 'self'; form-action 'self'; base-uri 'self'; object-src 'none';…

Need hands-on remediation? Email guard@offseq.com

Keep watching medivir.com

This scan found 21 issues across 6 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.

Daily monitoring

Recommended

€25per month

  • TLS certificates and expiry
  • DNS records
  • SPF, DKIM and DMARC
  • Security headers
  • GDPR and NIS2 posture
  • Exposed services
  • Third-party trackers
  • Security score drift

Email alerts on material changes and an exportable JSON history of every change.

Billed monthly to your card. Cancel anytime. See sample alerts.

Full report

€39.90one-time

  • The complete analysis as a PDF you can cite
  • Email delivery with an unlock code
  • Lifetime access to this report

Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.

Results by check

Each check with its score, findings and the evidence it collected.

How this score is calculated

The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.

Counted in this score

SSL/TLS
0
Security headers
15
Email security
85
DNS health
75
Network security
100
GDPR outside view
28
Average
51

Not counted

  • NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
  • OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.

Findings that cap the score at 49

Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.

  • The certificate is not trusted by browsers
  • The website is not served over HTTPS
  • A database, remote desktop, file-sharing or Telnet service is reachable from the internet
  • The page loads a script from a compromised source
  • The domain registration has expired
  • SPF authorises every server to send mail as the domain

Partial scans

When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.

Risk levels

  • Critical0–25
  • High26–49
  • Medium50–75
  • Low76–100

Technical appendix

Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.

Business context

Business profile

Medivir holds a specialized position in the healthcare sector focusing on cancer drug development. Their business model combines proprietary research with licensing and partnerships, enabling global reach and diversified revenue streams. The company targets patients, healthcare professionals, investors, and potential partners. The presence of detailed investor reports and presentations suggests a mature business with transparent communication. The partnership strategy is emphasized as a key element of growth and success. No parent or subsidiary companies were identified from the website content.

Security posture

The website demonstrates a mature security posture with HTTPS enforced and a cookie consent mechanism aligned with GDPR. However, the absence of explicit security headers such as Content-Security-Policy and lack of a published security policy or incident response contact reduces the overall security maturity. No vulnerabilities or exposed sensitive data were detected. The site does not provide a vulnerability disclosure policy or security.txt file, which could enhance transparency and trust. Incident response readiness and security culture indicators are not visible on the site.

Recommendations

  1. Implement and publish explicit security headers including Content-Security-Policy, X-Content-Type-Options, and X-Frame-Options.
  2. Publish a formal security policy and incident response contact information to improve transparency and readiness.
  3. Add a vulnerability disclosure policy or security.txt file to encourage responsible reporting of security issues.
  4. Enhance accessibility features to meet compliance standards and improve user experience for all visitors.
  5. Regularly audit and update third-party scripts and libraries to mitigate potential vulnerabilities.

Contact details published on the site

Addresses
Legal name
Medivir AB
Site observations

Automated reading of the public site. Ratings are indicative.

Business

Company
Medivir AB
Description
Medivir is a drug discovery and development company focusing on transformative cancer drugs. Their research and development are based on extensive expertise in protease inhibitor design and nucleoside/nucleotide science.
Key services
Drug discovery, Clinical development, Licensing projects, Partnership collaborations
Content quality
good
Branding
consistent

Technology

Stack
jQuery, Video.js, Headroom.js, Google Fonts (Roboto), Flickity carousel
Performance
moderate
Mobile
good
Accessibility
basic
SEO
good

Security

Observed score
85/100
Good practices seen
  • HTTPS enforced
  • No visible exposed sensitive data
  • Cookie consent banner implemented

Analytics and tracking

Tracking level
minimal
Privacy practices
good

Advertising

Transparency
poor

Site quality

Design
good
User experience
good
Content relevance
good
Navigation
good
Professionalism
good
Trustworthiness
high

Key observations

  1. Website is professionally designed and well-structured.
  2. Clear focus on pharmaceutical drug development for cancer.
  3. Comprehensive investor relations and news sections.
  4. Contact information is transparent with named executives.
  5. Cookie consent and privacy policy are implemented properly.
  6. No visible security policy or incident response information.
  7. No terms of service found.
  8. No vulnerability disclosure or security.txt present.
  9. No advertising or tracking scripts detected beyond essential libraries.
Technical notes

Notes

The website uses a modern technology stack including jQuery, Video.js for media, Headroom.js for UI behavior, and Flickity for carousels. Google Fonts are used for typography. The CMS is likely Umbraco, inferred from data attributes and URL patterns. Performance is moderate with asynchronous loading of styles and scripts. Mobile optimization is good, and SEO meta tags are well implemented. Accessibility is basic and could be improved. No hosting provider information was detected from the HTML content. The site does not appear to use heavy advertising or tracking technologies, which benefits privacy and performance.
Standards and sources

Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.

Retrieved 2026-10-25

Reviews of this site

Share your experience with medivir.com. Every review is verified by email and published after moderation.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

No published reviews yet. Be the first to review medivir.com.

Feedback on this report

Rate this report, add an optional comment, and tell us if you want a security specialist to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.